Dacarbazine, Nimustine Hydrochloride, Cisplatin and Tamoxifen Combination Chemotherapy for Advanced Malignant Melanoma

E-ISSN： 1346-8138|26|8|489-493

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.26, Iss.8, 1999-08, pp. : 489-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paralytic Ileus Associated with a Combination of Dacarbazine‐Nimustine Hydrochloride‐Vincristine Chemotherapy

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 10, 1997-10 ,pp. : 682-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 333-337

Karger

Access to resources Recommend Favorite

Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

Efficacy and safety of bio‐chemotherapy with dacarbazine plus interleukin‐2 in patients with unresectable malignant melanoma

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 314-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myelodysplastic Syndrome Following Treatment of Malignant Melanoma with Vincristine, ACNU, and Dacarbazine

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 3, 2000-03 ,pp. : 178-180

John Wiley & Sons Inc

Access to resources Recommend Favorite